Year |
Citation |
Score |
2010 |
Thaler S, Fiedorowicz M, Choragiewicz TJ, Bolz S, Tura A, Henke-Fahle S, Yoeruek E, Zrenner E, Bartz-Schmidt KU, Ziemssen F, Schuettauf F. Toxicity testing of the VEGF inhibitors bevacizumab, ranibizumab and pegaptanib in rats both with and without prior retinal ganglion cell damage. Acta Ophthalmologica. 88: e170-6. PMID 20491691 DOI: 10.1111/J.1755-3768.2010.01927.X |
0.364 |
|
2009 |
Tura A, Schuettauf F, Monnier PP, Bartz-Schmidt KU, Henke-Fahle S. Efficacy of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in the rodent retina. Investigative Ophthalmology & Visual Science. 50: 452-61. PMID 18757509 DOI: 10.1167/Iovs.08-1973 |
0.321 |
|
2008 |
Zhu Q, Ziemssen F, Henke-Fahle S, Tatar O, Szurman P, Aisenbrey S, Schneiderhan-Marra N, Xu X, Grisanti S. Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization. Ophthalmology. 115: 1750-5, 1755.e1. PMID 18708261 DOI: 10.1016/J.Ophtha.2008.04.023 |
0.313 |
|
2006 |
Spitzer MS, Wallenfels-Thilo B, Sierra A, Yoeruek E, Peters S, Henke-Fahle S, Bartz-Schmidt KU, Szurman P. Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells. The British Journal of Ophthalmology. 90: 1316-21. PMID 16723358 DOI: 10.1136/Bjo.2006.095190 |
0.37 |
|
2006 |
Szurman P, Kaczmarek R, Spitzer MS, Jaissle GB, Decker P, Grisanti S, Henke-Fahle S, Aisenbrey S, Bartz-Schmidt KU. Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells. Experimental Eye Research. 83: 584-92. PMID 16684520 DOI: 10.1016/J.Exer.2006.02.012 |
0.325 |
|
2006 |
Tatar O, Shinoda K, Adam A, Rohrbach JM, Lucke K, Henke-Fahle S, Bartz-Schmidt KU, Grisanti S. Expression of endostatin in human choroidal neovascular membranes secondary to age-related macular degeneration. Experimental Eye Research. 83: 329-38. PMID 16584730 DOI: 10.1016/J.Exer.2005.12.017 |
0.355 |
|
2006 |
Schraermeyer U, Kopitz J, Peters S, Henke-Fahle S, Blitgen-Heinecke P, Kokkinou D, Schwarz T, Bartz-Schmidt KU. Tyrosinase biosynthesis in adult mammalian retinal pigment epithelial cells. Experimental Eye Research. 83: 315-21. PMID 16579986 DOI: 10.1016/J.Exer.2005.12.015 |
0.334 |
|
2004 |
Grisanti S, Canbek S, Kaiserling E, Adam A, Lafaut B, Gelisken F, Szurman P, Henke-Fahle S, Oficjalska-Mlynczak J, Bartz-Schmidt KU. Expression of endoglin in choroidal neovascularization. Experimental Eye Research. 78: 207-13. PMID 14729353 DOI: 10.1016/J.Exer.2003.11.008 |
0.328 |
|
2003 |
Monnier PP, Sierra A, Schwab JM, Henke-Fahle S, Mueller BK. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Molecular and Cellular Neurosciences. 22: 319-30. PMID 12691734 DOI: 10.1016/S1044-7431(02)00035-0 |
0.326 |
|
2001 |
Henke-Fahle S, Wild K, Sierra A, Monnier PP. Characterization of a new brain-derived proteoglycan inhibiting retinal ganglion cell axon outgrowth. Molecular and Cellular Neurosciences. 18: 541-56. PMID 11922144 DOI: 10.1006/Mcne.2001.1034 |
0.359 |
|
2001 |
Monnier PP, Beck SG, Bolz J, Henke-Fahle S. The polysialic acid moiety of the neural cell adhesion molecule is involved in intraretinal guidance of retinal ganglion cell axons. Developmental Biology. 229: 1-14. PMID 11133150 DOI: 10.1006/Dbio.2000.9970 |
0.329 |
|
1996 |
Fahle M, Henke-Fahle S. Interobserver variance in perceptual performance and learning. Investigative Ophthalmology & Visual Science. 37: 869-77. PMID 8603871 |
0.429 |
|
1994 |
Fahle M, Henke-Fahle S, Harris J. Definition of thresholds for stereoscopic depth. The British Journal of Ophthalmology. 78: 572-6. PMID 7918271 DOI: 10.1136/bjo.78.7.572 |
0.417 |
|
1989 |
Fahle M, Barth V, Henke-Fahle S, Mohn G. [Assessment of visual acuity in simulation and aggravation]. Klinische MonatsbläTter FüR Augenheilkunde. 195: 356-62. PMID 2622122 DOI: 10.1055/S-2008-1050055 |
0.433 |
|
Show low-probability matches. |